UK Markets close in 3 hrs 36 mins

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
72.75+0.75 (+1.04%)
At close: 04:00PM EST
72.80 +0.05 (+0.07%)
After hours: 07:34PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.45
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3181.07
52-week low 371.11
50-day moving average 395.55
200-day moving average 3115.85

Share statistics

Avg vol (3-month) 31.12M
Avg vol (10-day) 31.49M
Shares outstanding 5101.66M
Implied shares outstanding 6N/A
Float 896.93M
% held by insiders 14.65%
% held by institutions 194.89%
Shares short (14 Dec 2021) 44.8M
Short ratio (14 Dec 2021) 43.82
Short % of float (14 Dec 2021) 44.94%
Short % of shares outstanding (14 Dec 2021) 44.72%
Shares short (prior month 14 Nov 2021) 43.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin -118.80%
Operating margin (ttm)-114.65%

Management effectiveness

Return on assets (ttm)-14.13%
Return on equity (ttm)-42.30%

Income statement

Revenue (ttm)343.86M
Revenue per share (ttm)3.41
Quarterly revenue growth (yoy)27.10%
Gross profit (ttm)194.19M
EBITDA -373.47M
Net income avi to common (ttm)-408.5M
Diluted EPS (ttm)-4.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.49B
Total cash per share (mrq)14.62
Total debt (mrq)1.36B
Total debt/equity (mrq)176.79
Current ratio (mrq)15.57
Book value per share (mrq)6.98

Cash flow statement

Operating cash flow (ttm)-191.25M
Levered free cash flow (ttm)-103.51M